Abstract
Glanders is a disease of antiquity, although occasional cases can still be found. This disease is naturally found in equines, who occasionally transmit the infection to humans (1). Glanders is one of the oldest diseases ever described. Disease symptoms were recorded by Hippocrates around the year 425 BC, and the disease was given the name “melis” by Aristotle in approx 350 BC. Glanders is suggested as the cause of the sixth plague of Egypt, as described in the Bible (2). However, this disease was not studied in a systematic matter until the early part of the 19th century. Through much of recorded history, glanders has been a world problem. Because of the serious problem posed by glanders in the French cavalry horses, the first veterinary school was established by King Louis XV at Lyons, France, in the mid-1800s. Unfortunately, many early investigators became infected during the course of their studies and died of glanders (3).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Miller, W. R., Pannell, L., Cravitz, L., Tanner, W. A., and Rosebury, T. (1948) Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. II. Virulence and infectivity for animals. J. Bacteriol. 55, 127–135.
Marr, J. S. and Malloy, C. D. (1996) An epidemiologic analysis of the ten plagues of Egypt. Caduceus 12, 7–23.
Wilkinson, L. (1981) Glanders: medicine and veterinary medicine in common pursuit of a contagious disease. Med. Hist. 25, 363–384.
Loeffler, F. (1886) The etiology of glanders (in German). Arb. Kaiserl. Gesundh. 1, 141–198.
Schadewaldt, H. (1975) 100 years in the mirror of the German Medical Weekly. The discovery of the bacillus for glanders (in German). German Med. Weekly 100, 2292–2295.
Struck, D. (1882) A preliminary report on work by the Imperial Health Care Office leading to the discovery of the glanders bacillus (in German). German Medical Weekly 52, 707, 708.
Benenson, A. S. (1995) Control of Communicable Diseases Manual. American Public Health Association, Washington, D.C.
Sanford, J. P. (1990) Pseudomonas species (including melioidosis and glanders), in Priciples and Practice of Infectious Diseases, 3rd ed. (Mandell, G. L., Douglas, Jr., R. G., and Bennett, J. E., eds.), Churchill Livingstone, New York, pp. 1692–1696.
CDC. (2000) Biological and chemical terrorism: strategic plan for preparedness and response. MMWR 49(No. RR-4), 1–14.
Steele, J. H. (ed.) (1979) Glanders, in CRC Handbook Series in Zoonoses. CRC, Boca Raton, FL, pp. 339–362.
Yabuuchi, E., Kosako, Y., Oyaizu, H., et al. (1992) Proposal of Burkholderia gen. nov. and transfer of seven species of the genus Pseudomonas homology group II to the new genus, with the type species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. Microbiol. Immunol. 36, 1251–1275.
Miller, W. R., Pannell, L., Cravitz, L., Tanner, W. A., and Ingalls, M. S. (1948) Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei. I. Morphology, cultivation, viability, and isolation from contaminated speciments. J. Bacteriol. 55, 115–126.
Hagebock, J. M., Schlater, L. K., Frerichs, W. M., and Olson, D. P. (1993) Serologic responses to the mallein test for glanders in solipeds. J. Vet. Diagn. Invest. 5, 97–99.
Pitt, T. L. (1990) Pseudomonas mallei and Pseudomonas pseudomallei, in Topley & Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed. (Parker, M. T. and Collier, L. H., eds.), BC Decker, Philadelphia, PA, pp. 265–268.
Parker, M. (1990) Glanders and melioidosis, in Topley & Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed. (Parker, M. T. and Collier, L. H., eds.), BC Decker, Philadelphia, PA, pp. 392–394.
Vyshelesskii, S. N. (1974) Glanders (Equina). Trudy Vsessoiuznyi Institut Eksperimental’noi Veterinarii (in Russian) 42, 67–92.
Schlater, L. K. (1992) Glanders, in Current Therapy in Equine Medicine. (Robinson, N. E., ed.), W.B. Suanders, St. Louis, MO, pp. 761, 762.
Smith, G. R. and Easman, C. S. F. (1990) Bacterial diseases, in Topley & Wilson’s Principles of Bacteriology, Virology and Immunity. (Parke, r. M. T. and Collie, r. L. H., eds.), B.C. Decker, Philadelphia, PA, pp. 392–397.
Arun, S., Neubauer, H., Gurel, A., et al. (1999) Equine glanders in Turkey. Vet. Rec. 144, 255–258.
Smith, G. R., Pearson, A. D., and Parker, M. T. (1990) Pasteurella infections, tularemia, glanders and melioidosis, in Topley and Wilson’s Principles of Bacteriology, Virology and Immunity, 8th ed. (Smith, G. R. and Easman, C. S. F., eds.), B.C. Decker, Philadelphia, PA, pp. 392–397.
Huidekeoper, R. S. (1907) General diseases, in Diseases of the Horse. (Melvin, A. D., ed.), Government Printing Office, Washington, DC, pp. 532–545.
Sanford, J. P. (1991) Melioidosis and Glanders, in Harrison’s Principles of Internal Medicine, 12th ed. (Wilson, J. D., Braunwald, E., Isselbacher, K. J., et al., eds.), McGraw-Hill, New York, pp. 606–609.
Hornick, R. B. (1982) Diseases due to Pseudomonas mallei and Pseudomonas pseudomallei, in Infections in Children. (Wedgewood, R. J., ed.), Harper & Row, Philadelphia, PA, pp. 910–913.
Robins, G. D. (1906) A study of chronic glanders in man. Studies from the Royal Victoria Hospital 2, 1–98.
Redfearn, M. S. and Palleroni, N. J. (1975) Glanders and melioidosis, in Diseases Transmitted from Animals to Man. (Hubbert, W. T., McCulloch, W. F., and Schnurrenberger, P. R., eds.), Charles C. Thomas, Springfield, IL, 110–128.
Alibasoglu, M., Yesildere, T., Calislar, T., Inal, T., and Calsikan, U. (1986) Malleus outbreak in lions in the Istanbul Zoo (in German). Berl. Munch. Tierarztl. Wschr. 99, 57–63.
Gaiger, S. H. (1913) Glanders in man. J. Comp. Pathol. Ther. 26, 223–236.
(1924) Glanders. Foreign letter from Prague. J. Am. Med. Assoc. 82, 646.
Howe, C. and Miller, W. R. (1947) Human glanders: report of six cases. Ann. Intern. Med. 26, 93–115.
Hunter, D. H. (1936) Saints and martyrs. Lancet 231, 1131–1134.
Srinivasan, A., Kraus, C. N., DeShazer, D., et al. (2001) Glanders in a military microbiologist. N. Engl. J. Med. 354, 256–258.
Stewart, J. C. (1904) Pyaemic glanders in the human subject. Ann. Surg. 40, 109–113.
Redfearn, M. S., Palleroni, N. J., and Stanier, R. Y. (1966) A comparative study of Pseudomonas pseudomallei and Bacillus mallei. J. Gen. Microbiol. 43, 293–313.
Steele, J. H. (1973) The zoonoses: an epidemiologist’s viewpoint. Prog. Clin. Pathol. 5, 239–286.
CDC. (2000) Laboratory-acquired human glanders-Maryland, May 2000. MMWR 49, 532–535.
Kantseva, A. P. and Matkovskii, V. S. (1970) Specific lung disorders is especially dangerous and some little studied infections (in Russian). Voennomeditsinkij Zhurnal 7, 82–86.
Gaiger, S. H. (1916) Glanders in man. A second attack after apparent recovery. J. Comp. Path. 29, 26–46.
Ferster, L. N. and Kurilov, V. (1982) Characteristics of the infectious process in animals susceptible and resistant to glanders (in Russian). Arkh. Patol. 44, 24–30.
Fritz, D. L., Vogel, P., Brown, D. R., and Waag, D. M. (1999) The hamster model of intraperitoneal Burkholderia mallei (glanders). Vet. Pathol. 36, 276–291.
Fritz, D. L., Vogel, P., Brown, D. R., DeShazer, D., and Waag, D. M. (2000) Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet. Pathol. 37, 626–636.
Fritz, D., Miller, L., England, M., and Waag, D. (2001) Mouse model of aerosolized glanders (Burkholderia mallei). Vet. Pathol. 38, 591.
Rosenbloom, M., Leikin, J. B., Vogel, S. N., and Chaudry, Z. A. (2002) Biological and chemical agents: a brief synopsis. Am. J. Ther. 9, 5–14.
Finlay, B. B. and Falkow, S. (1997) Common themes in microbial pathogenesis revisited. Microbiol. Mol. Biol. Rev. 61, 136–169.
Henderson, I. R. and Nataro, J. P. (2001) Virulence functions of autotransporter proteins. Infect. Immun. 69, 1231–1243.
Zhu, J., Miller, M. B., Vance, R. E., Dziejman, M., Bassler, B. L., and Mekalanos, J. J. (2002) Quorum-sensing regulators control virulence gene expression in Vibrio cholerae. Proc. Natl. Acad. Sci. 99, 3129–3134.
Roberts, I. S. (1996) The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50, 285–315.
Moxon, E. R. and Kroll, J. S. (1990) The role of bacterial polysaccharide capsules as virulence factors. Curr. Top. Microbiol. Immunol. 150, 65–85.
Jennings, W. E. (1963) Glanders, in Diseases Transmitted from Animals to Man, 5th ed. (Hull, T. G., ed.), Charles C. Thomas, Springfield, IL, pp. 264–292.
Kovalev, G. K. (1971) Glanders (Review) (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. 48, 63–70.
Minett, F. C. (1959) Glanders (and melioidosis), in Infectious Diseases of Animals. Diseases due to Bacteria. (Stableforth, A. W., ed.), Academic Press, New York, pp. 296–318.
DeShazer, D., Waag, D. M., Fritz, D. L., and Woods, D. E. (2001) Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant. Microb. Pathogen. 30, 253–269.
Popov, S. F., Mel’nikov, B. I., Lagutin, M. P., and Kurilov, V. Y. (1991) Capsule formation in the causative agent of glanders (in Russian). Mikrobiol. Zh. 53(1), 90–92.
Popov, S. F., Kurilov, V. Y., and Yakovlev, A. T. (1995) Pseudomonas pseudomallei and Pseudomonas mallei-capsule-forming bacteria (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. (5), 32–36.
Popov, S. F., Tikhonov, N. G., N. N. P, Kurilov, V. Y., and Dement’ev, I. P. (2000) The role of capsule formation in Burkholderia mallei for its persistence in vivo (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. (3), 73–75.
Reckseidler, S. L., DeShazer, D., Sokol, P. A., and Woods, D. E. (2001) Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant. Infect. Immun. 69, 34–44.
Brett, P. J., DeShazer, D., and Woods, D. E. (1997) Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol. Infect. 118, 137–148.
Brett, P. J., DeShazer, D., and Woods, D. E. (1998) Burkholderia thailandensis sp. nov., description of a Burkholderia pseudomallei-like species. Int. J. Syst. Bacteriol. 48, 317–320.
Smith, M. D., Angus, B. J,. Wuthiekanun, V., and White, N. J. (1997) Arabinose assimilation defines a nonvirulent biotype of Burkholderia pseudomallei. Infect. Immun. 65, 4319–4321.
Ochman, H., Lawrence, J. G., and Groisman, E. A. (2000) Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299–304.
Whitfield, C. and Roberts, I. S. (1999) Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol. Microbiol. 31, 1307–1319.
Khrapova, N. P., Tikhonov, N. G., and Prokhvatilova, Y. V. (1998) Detection of glycoprotein of Burkholderia pseudomallei. Emerging Infect. Dis. 4, 336, 337.
Piven, N. N., Smirnova, V. I., Viktorov, D. V., et al. (1996) Immunogenicity and heterogeneity of Pseudomonas pseudomallei surface antigen 8 (in Russian). Zh. Mikrobiol. (Moscow) 4, 75–78.
Samygin, V. M., Khrapova, N. P., Spiridonov, V. A., and Stepin, A. A. (2001) Antigen 8 biosynthesis during cultivation of Burkholderia pseudomallei and B. mallei (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. 4, 50–52.
DeShazer, D., Brett, P. J., and Woods, D. E. (1998) The type II O-antigenic polysaccharide moiety of Burkholderia pseudomallei lipopolysaccharide is required for serum resistance and virulence. Mol. Microbiol. 30, 1081–1100.
Burtnick, M. N., Brett, P. J., and Woods, D. E. (2002) Molecular and physical characterization of Burkholderia mallei O antigens. J. Bacteriol. 184, 849–852.
Pitt, T. L., Aucken, H., and Dance, D. A. (1992) Homogeneity of lipopolysaccharide antigens in Pseudomonas pseudomallei. J. Infect. 25, 139–146.
Knirel, Y. A., Paramonov, N. A., Shashkov, A. S., et al. (1992) Structure of the polysaccharide chains of Pseudomonas pseudomallei lipopolysaccharides. Carbohydrate Res. 233, 185–193.
Perry, M. B., MacLean, L. L., Schollaardt, T., Bryan, L. E., and Ho, M. (1995) Structural characterization of the lipopolysaccharide O antigens of Burkholderia pseudomallei. Infect. Immun. 63, 3348–3352.
Day, W. A. J., Fernandez, R. E., and Maurelli, A. T. (2001) Pathoadaptive mutations that enhance virulence: genetic organization of the cadA regions of Shigella spp. Infect. Immun. 69, 7471–7480.
Maurelli, A. T., Fernandez, R. E., Bloch, C. A., Rode, C. K., and Fasano, A. (1998) “Black holes” and bacterial pathogenicity: a large genomic deletion that enhances the virulence of Shigella spp. and enteroinvasive Escherichia coli. Proc. Natl. Acad. Sci. 95, 3943–3948.
Mira, A., Ochman, H., and Moran, N. A. (2001) Deletional bias and the evolution of bacterial genomes. Trends Genet. 17, 589–596.
Parkhill, J., Wren, B. W., Thomson, N. R., et al. (2001) Genome sequence of Yersinia pestis, the causative agent of plague. Nature 413, 523–527.
Steinmetz, I., Rohde, M., and Brenneke, B. (1995) Purification and characterization of an exopolysaccharide of Burkholderia (Pseudomonas) pseudomallei. Infect. Immun. 63, 3959–3965.
Nimtz, M., Wray, V., Domke, T., Brenneke, B., Haussler, S., and Steinmetz, I. (1997) Structure of an acidic exopolysaccharide of Burkholderia pseudomallei. Eur. J. Biochem. 250, 608–616.
Wretlind, B., Becker, K., and Haas, D. (1985) IncP-1 R plasmids decrease the serum resistance and the virulence of Pseudomonas aeruginosa. J. Gen. Microbiol. 131, 2701–2704.
Verevkin, V. V., Volozhantsev, N. V., Myakinina, V. P., and Svetoch, E. A. (1997) Effect of the TRA-system of RP4 and R68.45 plasmids on virulence of the glanders agent (in Russian). Vestn. Ross. Akad. Med. Nauk. 6, 37–40.
Shipovskaia, N. P., Merinova, L. K., and Riapis, L. A. (1983) Properties of auxotrophic mutants of Pseudomonas mallei (in Russian). Zh. Mikrobiol. Epidemiol. Immunobiol. 4, 36–39.
Alibek, K. and Handelman, S. (1999) Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World. Random House, New York.
Neubauer, H., Meyer, H., and Finke, E. J. (1997) Human glanders. Revue Internationale Des Services De Sante Des Forces Armees 70, 258–265.
Evans, D. H. (1966) Colonial variation in Actinobacillus mallei. Can. J. Microbiol. 12, 609–616.
Heine, H. S., England, M. J., Waag, D. M., and Byrne, W. R. (2001) In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test. Antimicrob. Agents Chemother. 45, 2119–2121.
Kenny, D. J., Russell, P., Rogers, D., Eley, S. M., and Titball, R. W. (1999) In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp. Antimicrob. Agents Chemother. 43, 2773–2775.
Abaev, I. V., Akimova, L. A., Shitov, V. T., Volozhantsev, N. V., and Svetoch, E. A. (1992) Transformation of pathogenic pseudomonads by plasmid DNA (in Russian). Mol. Gen. Mikrobiol. Virusol. 3–4, 17–20.
Abaev, I. V., Astashkin, E. I., Pachkunov, D. M., Stagis, I. I., Shitov, V. T., and Svetoch, E. A. (1995) Pseudomonas mallei and Pseudomonas pseudomallei: introduction and maintenance of natural and recombinant plasmid replicons (in Russian). Mol. Gen. Mikrobiol. Virusol. 1, 28–36.
Abaev, I. V., Pomerantseva, O. M., Astashkin, E. I., et al. (1997) The creation of genomic DNA libraries of Pseudomonas mallei and Pseudomonas pseudomallei (in Russian). Mol. Gen. Mikrobiol. Virusol. 1, 17–22.
Ageeva, N. P. and Merinova, L. K. (1986) The effect of mating conditions on the effectiveness of transmitting RP4 plasmids in Pseudomonas mallei (in Russian). Mikrobiol. Zh. 48(5), 3–6.
Ageeva, N. P., Merinova, L. K., and Peters, M. K. (1989) The use of the plasmid pTH10 for isolating the donor strains of Pseudomonas mallei (in Russian). Mol. Gen. Mikrobiol. Virusol. 4, 14–18.
Anishchenko, M. A. and Merinova, L. K. (1992) Mobilization using incompatibility group P1 plasmids in strains of Pseudomonas pseudomallei and Pseudomonas mallei as potential vectors for DNA cloning (in Russian). Mol. Gen. Mikrobiol. Virusol. 5–6, 13–16.
Burtnick, M. N., Bolton, A. J., Brett, P. J., Watanabe, D., and Woods, D. E. (2001) Identification of the acid phosphatase (acpA) gene homologues in pathogenic and non-pathogenic Burkholderia spp. facilitates TnphoA mutagenesis. Microbiology 147, 111–120.
Filonov, A. E., Manzeniuk, I. N., and Svetoch, E. A. (1996) Conjugative transfer and expression of R plasmids of the genus Pseudomonas in the cells of Pseudomonas mallei C-5 (in Russian). Antibiot. Khimioter. 41(3), 20–24.
Manzeniuk, O. I., Volozhantsev, N. V., Astashkin, E. I., and Svetoch, E. A. (1993) Transduction of Pseudomonas mallei bacteria (in Russian). Mol. Gen. Mikrobiol. Virusol. 4, 37–40.
Peters, M. K., Shipovskaia, N. P., and Merinova, L. K. (1983) A study of the possibility of conjugated transmission of the RP4 plasmid from Pseudomonas aeruginosa by strains of Pseudomonas mallei and Pseudomonas pseudomallei (in Russian). Mikrobiol. Zh. 45(3), 11–14.
Woods, D. E., Jeddeloh, J. A., Fritz, D. F., and DeShazer, D. (2002) Burkholderia thailandensis E125 harbors a temperate bacteriophage specific for Burkholderia mallei. J. Bacteriol. 184, 4003–4017.
Merinova, L. K., Antonov, V. A., Zamaraev, V. S., and Viktorov, D. V. (2000) Mobilization of a cryptic plasmid from the melioidosis pathogen in heterologous species of microorganisms (in Russian). Mol. Gen. Mikrobiol. Virusol. 2, 37–40.
Figurski, D. H. and Helinski, D. R. (1979) Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc. Natl. Acad. Sci. 76, 1648–1652.
Simon, R., Priefer, U., and Puhler, A. (1983) A broad host range mobilization system for in vivo genetic engineering: tranposon mutagenesis in gram negative bacteria. Bio/Technology 1, 784–791.
Reyrat, J.-M., Pelicic, V., Gicquel, B., and Rappuoli, R. (1998) Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect. Immun. 66, 4011–4017.
Berg, C. M., Berg, D. E., and Groisman, E. A. (1989) Transposable elements and the genetic engineering of bacteria, in Mobile DNA. (Berg, D. E. and Howe, M. M., eds.), American Society for Microbiology, Washington, DC, pp. 879–925.
Dennis, J. J. and Zylstra, G. J. (1998) Plasposons: modular self-cloning minitransposon derivatives for rapid genetic analysis of Gram-negative bacterial genomes. Appl. Environ. Microbiol. 64, 2710–2715.
Berg, D. E. (1989) Transposon Tn5, in Mobile DNA. (Berg, D. E. and Howe, M. M., eds.), American Society for Microbiology, Washington, DC, pp. 185–210.
De Lorenzo, V., Herrero, M., Jakubzik, U., and Timmis, K. N. (1990) Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria. J. Bacteriol. 172, 6568–6572.
Grishkina, T. A. and Merinova, L. K. (1993) Spontaneous phage production in Pseudomonas pseudomallei and in a range of hosts of melioidosis phages among representatives in the genus Pseudomonas (in Russian). Mikrobiol. Z. 55(4), 43–47.
Manzeniuk, O. I., Volozhantsev, N. V., and Svetoch, E. A. (1994) Identification of Pseudomonas mallei bacteria with the help of Pseudomonas pseudomallei bacteriophages (in Russian). Mikrobiologiia 63(3), 537–544.
Smith, P. B. and Cherry, W. B. (1957) Identification of Malleomyces by specific bacteriophages. J. Bacteriol 74, 668–672.
Harayama, S., Tsuda, M., and Lino, T. (1980) High frequency mobilization of the chromosome of Escherichia coli by a mutant of plasmid RP4 temperature-sensitive for maintenance. Mol. Gen. Genet. 180, 47–56.
Mahillon, J. and Chandler, M. (1998) Insertion sequences. Microbiol. Mol. Biol. Rev. 62, 725–774.
Berge, A., Rasmussen, M., and Bjorck, L. (1998) Identification of an insertion sequence located in a region encoding virulence factors of Streptococcus pyogenes. Infect. Immun. 66, 3449–3453.
Sharrer, G. T. (1995) The great glanders epizootic, 1861–1866. Agricultural History 69, 79–97.
Witcover, J. (1989) Sabotage at Black Tom: Imperial Germany’s Secret War in America, 1914–1917. Algonquin Books of Chapel Hill, Chapel Hill, NC.
Carus, W. S. (1998) Bioterrorism and biocrimes: the illicit use of biological agents in the 20th century. National Defense University: Center for Counterproliferation Research.
Mohler, J. R. and Eichhorn, A. (1914) Immunization tests with glanders vaccine. J. Comp. Path. 27, 183–185.
Amemiya, K., Bush, G. V., DeShazer, D., and Waag, D. M. (2002) Nonviable Burkholderia mallei induces a mixed Th1-and Th2-like cytokine response in BALB/c mice. Infect. Immun. 70, 2319–2325.
Schutz, K. and Schubert, O. (1909) Die Ermittelung der Rotzkrankheit mit Hilfe der Komplementablekungsmethod (in German). Arch. Wiss. Prakt. Tierhlk. 35, 44–83.
Gangulee, P. C., Sen, G. P., and Sharma, G. L. (1966) Serological diagnosis of glanders by haemagglutination test. Indian Vet. J. 43, 386–391.
Sen, G. P., Singh, G., and Joshi, T. P. (1968) Comparative efficacy of serological tests in the diagnosis of glanders. Indian Vet. J. 45, 286–293.
Bauernfeind, A., Roller, C., Meyer, D., Jungwirth, R., and Schneider, I. (1998) Molecular procedure for rapid detection of Burkholderia mallei and Burkholderia pseudomallei. J. Clin. Microbiol. 36, 2737–2741.
Tyler, S. D., Strathdee, C. A., Rozee, K. R., and Johnson, W. M. (1995) Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers. Clin. Diag. Lab. Immunol. 2, 448–453.
Trakulsomboon, S., Dance, D. A. B., Smith, M. D., White, N. J., and Pitt, T. L. (1997) Ribotype differences between clinical and environmental isolates of Burkholderia pseudomallei. J. Med. Microbiol. 46, 565–570.
Al-Ani, F. K., Al-Rawashdeh, O. F., Ali, A. H., and Hassan, F. K. (1998) Glanders in horses: clinical, biochemical and serological studies in Iraq. Vet. Arhiv. 68, 155–162.
Al-Izzi, S. A. and Al-Bassam, L. S. (1989) In vitro susceptibility of Pseudomonas mallei to antimicrobial agents. Comp. Immunol. Microbiol. Infect. Dis. 12, 5–8.
Batmanov, V. P. (1991) Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders (in Russian). Antibiot. Khimioter. 36, 31–34.
Batmanov, V. P. (1994) Sensitivity of Pseudomonas mallei to tetracyclines and their effectiveness in experimental glanders (in Russian). Antibiot. Khimioter. 39, 33–37.
Iliukhin, V. I., Alekseev, V. V., Antonov, I. V., Savchenko, S. T., and Lozovaia, N. A. (1994) Effectiveness of treatment of experimental glanders after aerogenic infection (in Russian). Antibiot. Khimioter. 39, 45–48.
Ipatenko, N. G. (1972) Bacteriostatic and bactericidal action of some antibiotic on the glanders bacillus, Bacillus (Actinobacillus) mallei (in Russian). Trudy Moskovskoi Veterinarnoi Akademii 61, 142–148.
Kovalev, G. K. and Gnetnev, A. M. (1975) Antibiotic sensitivity of the causative agent of glanders (in Russian). Antibiotiki 20, 141–144.
Manzeniuk, I. N., Dorokhin, V. V., and Svetoch, E. A. (1994) The efficacy of antibacterial preparations against Pseudomonas mallei in in-vitro and in-vivo experiments (in Russian). Antibiot. Khimioter. 39, 26–30.
Miller, W. R., Pannell, L., and Ingalls, M. S. (1948) Experimental chemotherapy in glanders and melioidosis. Am. J. Hyg. 47, 205–213.
Muhammad, G., Khan, M. Z., and Athar, M. (1998) Clinico-microbiological and therapeutic aspects of glanders in equines. J. Equine Sci. 9, 93–96.
Nagy, G. and Zalay, L. (1967) Antibiotic sensitivity and biochemical properties of Bact. mallei strains used in diagnostic preparations. Acta Vet. Acad. Sci. Hung. 17, 285–286.
Stepanshin, I. G., Manzeniuk, I. N., Svetoch, E. A., and Volkovoi, K. I. (1994) In vitro development of fluoroquinolone resistance in the glanders pathogen (in Russian). Antibiot. Khimioter. 39, 30–33.
Tezok, F. (1958) Three glanders strains isolated from three patients in 1956 and differing with regard to sensitivity to antibiotics. Internat. Congr. Microbiol. Abstr. VII, 344.
Yolv, Y. (1967) Effect of certain antibiotics, sulphonamides and other substances on the reproduction of Pfeifferella (Actinobacillus) mallei in vitro. Vet. Med. Nauki. Sofia 4, 55–59.
Russell, P., Eley, S. M., Ellis, J., et al. (2000) Comparison of efficacy of ciprofloxacin and doxycycline against experimental melioidosis and glanders. J. Antimicrob. Chemother. 45, 813–818.
Tribuddharat, C., Moore, R. A., Baker, P., and Woods, D. E. (2003) Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob. Agents Chemother. 47, 2082–2087.
Batmanov, V. P. (1993) Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim (in Russian). Antibiot. Khimioter. 38, 18–22.
Manzeniuk, I. N., Manzeniuk, O. I., Filonov, A. V., Stepanshin, I. G., and Svetoch, E. A. (1995) Resistance of Pseudomonas mallei to tetracyclines: assessment of the feasibility of chemotherapy (in Russian). Antibiot. Khimioter. 40, 40–44.
Howe, C. (1950) Glanders, in The Oxford Medicine. (Christian, H. A., ed.), Oxford University Press, New York, pp. 185–202.
Ansabi, M. and Minou, M. (1951) Two cases of chronic human glanders treated with sulfamides (in French). Ann. Inst. Pasteur 81, 98–102.
Womack, C. R. and Wells, E. B. (1949) Co-existent chronic glanders and multiple cystic osseous tuberculosis treated with streptomycin. Am. J. Med. 6, 267–271.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Waag, D.M., DeShazer, D. (2005). Glanders. In: Lindler, L.E., Lebeda, F.J., Korch, G.W. (eds) Biological Weapons Defense. Infectious Disease. Humana Press. https://doi.org/10.1385/1-59259-764-5:209
Download citation
DOI: https://doi.org/10.1385/1-59259-764-5:209
Publisher Name: Humana Press
Print ISBN: 978-1-58829-184-4
Online ISBN: 978-1-59259-764-2
eBook Packages: MedicineMedicine (R0)